Rainer Kramer, Ph.D.
(Managing Director, Chief Business Officer)
Dr. Rainer Kramer joined immatics as Chief Business Officer in April 2012 from Signature Diagnostics AG where he was Chief Business Officer as well. He is primarily responsible for immatics’ licensing & partnering activities.
During his career he has delivered numerous strategic partnerships and license deals encompassing tech-nology platform and product deals as well as equity transactions with an aggregate value of several hundred million Euros whilst working in business development functions at Jerini AG, MorphoSys AG, Martinsried, and Amgen Inc. During the sale of Jerini to Shire in 2008 he was a member of Jerini’s M&A committee and Shire’s appointed principal for sale of JPT GmbH in 2009.
Dr. Kramer holds a Diploma in Molecular Biology from University of Regensburg and a PhD from Max-Planck-Institute for Neurobiology.